Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
about
Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease.Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.Placental extract ameliorates non-alcoholic steatohepatitis (NASH) by exerting protective effects on endothelial cells.Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide.Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model.Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease.Characterisation of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease.Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis.Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model.Characterization of Ageing- and Diet-Related Swine Models of Sarcopenia and Sarcopenic Obesity.A Simple Diet- and Chemical-Induced Murine NASH Model with Rapid Progression of Steatohepatitis, Fibrosis and Liver Cancer.Key Inflammatory Processes in Human NASH Are Reflected in Ldlr-/-.Leiden Mice: A Translational Gene Profiling Study.Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
P2860
Q36159376-2A2A2796-DC6E-4E85-A996-0307AA6250DBQ36194038-58DB7A0C-D8A3-454B-A333-4CD3FA468CD1Q37381302-3834114A-F1AE-4A49-AA9E-CE4BE1AF79DAQ38737633-BA565DE3-6524-45EC-BF7B-E6F91195FA90Q38814148-5CAA3BFD-5DCB-49B5-91A4-E590A1FEDBD9Q38858268-DF7FBC0B-F2C2-4D2A-A5D6-15DCF5529C85Q39044686-4F50E11B-D2A8-425C-A1CE-1201608CE197Q39333577-00563E8D-BE04-4109-BB1A-59DD61D81689Q39445103-E86FF39C-D4A9-40CB-8DAB-6CFAD2B2E383Q40154406-27D8A744-0D8A-49DB-B144-A1C14744FCC4Q41471996-FB9BF298-8E25-43E3-BD12-F760B20594D7Q42277188-606863BF-C2B6-4B53-9BD9-80585BF53D2DQ46270590-D19D3C7F-0F6D-4E77-BB88-74B1934B4290Q46450900-48646476-21E3-4005-9E39-883736A7F6CDQ47106480-C0CCE40C-67C3-4B4B-A41A-FA1745346CADQ47128868-B8B393FE-1327-4489-B422-1293B234532AQ47154314-C87571C9-711F-4FAD-9B82-E05E6AF7C5FCQ47339318-E415DA6B-7F50-4A9A-87F5-C6D67F56C170Q47595575-335018CD-B223-405D-A182-BA03EDAE375EQ49287362-BE6CFEFF-136F-478E-B2CC-9D2164469239Q49569072-5A7EB8AA-A51B-4363-822E-D1FBC1A0ABB6Q51050107-D38F317A-D1A5-47A9-8DA8-A4205AE0F04CQ51763545-1CE2550D-E9A3-4F62-8C04-9D95EC56D238Q52639618-D5CE7584-6496-4C15-BA58-ECFDE935D65CQ55071759-F22F3E4D-E1D9-41C6-9255-4AF703FF3D71Q55358328-9A6F58AB-193A-4C90-8388-CE4087267BC4
P2860
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@ast
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@en
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@nl
type
label
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@ast
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@en
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@nl
prefLabel
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@ast
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@en
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@nl
P2093
P2860
P3181
P1476
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
@en
P2093
Harmeet Malhi
Petra Hirsova
Samar H Ibrahim
P2860
P2888
P304
P3181
P356
10.1007/S10620-015-3977-1
P407
P577
2016-05-01T00:00:00Z
P5875
P6179
1003319782